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Summary Several studies have revealed an excess of malformations in children with certain malignancies. A
few environmental causes have been identified which may damage the foetus and lead to malformation and
cancer. However, most of the numerous recognised cancer/malformation syndromes are genetically deter-
mined.
This report describes a case-control study of 555 newly diagnosed children with cancer and 1,110 matched
controls, chosen from general practitioner lists (GP controls) and hospital admissions (H controls). Their
parents were interviewed on topics of possible aetiological significance and medical records were checked to
confirm reports at interview. The numbers of congenital malformations in the index and GP control children,
and the relatives of the index children, the GP and H controls are described.
There were more children with malformations among the cases (60/555) than among the GP controls
(27/555), P<0.001. The abnormalities in the cases included eight with specific chromosomal/genetic conditions
(e.g. Down's syndrome, XY gonadal dysgenesis, Von Recklinghausen's neurofibromatosis, Goldenhar's syn-
drome) whereas only one GP control child had a chromosomal defect (P<0.05). Five case children but no GP
controls had neural tube defects; this is not statistically significant.
No excess of malformations was found in the siblings of cases compared with GP and H control siblings.
Case mothers had a small excess of malformations (22/555) compared with GP controls (8/555), P<0.05.
Among more distant relatives the results were difficult to interpret because of the relatively small numbers in
the diagnostic subgroups and because of apparent under reporting in grandparents, but no striking differences
were seen between case and control relatives.
The excess ofmalformations found in children with cancer, compared with controls, without a similar excess
of malformations in their close relatives may indicate that in some (perhaps very roughly one in 20) cases
antenatal events may lead both to the malformation and the malignancy.
In Western developed countries childhood cancers represent
only about 0.5% of all human cancers and differ in many
ways from those in adults. In these countries about one third
are acute leukaemias, 10-15% lymphomas, 28% central ner-
vous system tumours and 15% various types of embryonic
tumours. On the other hand, adult cancers are mostly car-
cinomas, 'associated with prolonged exposure to a hostile
environment' (Dodet & Lenoir, 1990). About 40% of
paediatric malignancies in Western countries develop before
the age of 5 years and the few environmental causes so far
identified have mostly exerted their effect ante-natally and
may also lead to malformation. Examples have been
antenatal exposure to diethylstilboestrol causing adenocar-
cinoma of the vagina, dysplasia of vagina and cervix and
maldescent and tumour of the testis (Herbst et al., 1971;
Bibbo et al., 1977; Brown et al., 1986); antenatal diagnostic
irradiation and subsequent cancers especially leukaemias
(Stewart et al., 1956) or mental retardation (Mole, 1979);
antenatal exposure to phenytoin causing the foetal hydantoin
syndrome and neuroblastoma (Allen et al., 1980; Ehrenbard
& Chaganti, 1981); and adrenal carcinoma (Hornstein et al.,
1977) or hepatoblastoma (Khan et al., 1979) associated with
foetal alcohol syndrome caused by antenatal exposure to
alcohol (though the associations between childhood cancer
and antenatal exposure to either alcohol or phenytoin are
based only on case reports, not controlled studies).
On the whole genetically determined factors seem to be
more important than environmental agents in the aetiology
of childhood cancers, although they may interact with each
other. Knudson proposed a 'two mutation' or 'two hit'
hypothesis for the development of retinoblastoma (Knudson,
1971; Hethcote & Knudson, 1978; Knudson, 1978) which has
since been shown by DNA technology to be correct (Cavenee
et al., 1983) and may apply to several other childhood
cancers too. However, although a large number of specific
anomalies has been described in association with certain
childhood cancers (Schimpke, 1978; Knudson, 1986; Dodet &
Lenoir, 1990) such as sporadic aniridia, genito-urinary
anomalies and mental retardation with Wilms' tumour due to
chromosome lIp 13 deletions (Riccardi et al., 1978) there
have also been reports of an excess of various less specific
anomalies in children with Wilms' tumour (Miller et al.,
1964), germ cell tumours (Birch, 1980; Birch et al., 1982;
Johnston et al., 1986), rhabdomyosarcomas (Ruymann et al.,
1988) and liver tumours (Mann et al., 1990).
The purposes of the investigation described in this report
were to quantify the association of congenital malformations
with childhood cancers, and, by studying the incidence of
malformations in relatives, to determine to what extent these
were inherited and to what extent they might represent new
mutations. In addition, family pedigrees were examined for
evidence of known and hitherto unrecognised cancer-
associated syndromes.
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The parents of 555 children who were newly diagnosed to
have cancer and resident in the West Midlands, North West
and Yorkshire Health Authority Regions in England were
interviewed with a standard questionnaire. Each case child
was matched for age and sex with two control children
selected from general practitioner lists, designated GP con-
trols (GPC), and hospital admissions, designated hospital
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controls (HC). The detailed methodology, which has been
described elsewhere (Birch et al., 1985), included the verifi-
cation of information gained at interview by reference to
medical records, both of cases and controls. This process
included examination of the obstetric records and the general
practitioners' records for all cases and controls, irrespective
of whether a malformation in the index child had been
reported at interview. Appropriate research ethical committee
approvals were obtained.
Congenital malformations in the index children and their
relatives were defined as those defects listed in Chapter XIV
of The Ninth Revision of the International Classification of
Diseases (WHO, 1977) and also neurofibromatosis, con-
genital deafness and congenital and infantile hernia. For the
index children we included, in addition, sacral dimples and
tufts of hair over the lumbo-sacral spine. In studying the
incidence of congenital malformations in the index children,
only the cases and GPC were compared, since children with
major defects were not considered eligible to be HC (Birch et
al., 1985). For siblings, parents, grandparents and 'other
relatives' (uncles, aunts, half uncles, half aunts and cousins),
comparisons were made between the numbers of malforma-
tions in these relatives of case, GPC and HC children. For
index children, siblings and parents, only malformations
which had been confirmed by inspection of medical records
were used in the analysis but for grandparents and 'other
relatives', whose records were often unobtainable, malforma-
tions reported at interview were analysed. For all relatives we
excluded birthmarks, naevi, skin tags, cafe au lait spots and
any condition of dubious significance. Anomalies in stillborn
relatives were included in the analyses. Maternal half siblings
were included in the sibling totals.
Tables for case-control comparisons were produced using
SPSS-X (1985). Yates correction was included in the analysis.
McNemar's matched pair analysis was used for comparison
of congenital anomalies in the index cases and GP control
children and also for comparison of case and control parents
(Fleiss, 1973).
Results
The total numbers of individuals with congenital malforma-
tions among the case and control groups are shown in
respect of the index children, their siblings, parents, grand-
parents and other relatives in Table I.
Index children
The numbers of children with congenital malformations in
the cases and GP controls are shown for each diagnostic
group in Table II. There were more case than control child-
ren with malformations in nine of the 14 diagnostic groups:
however the only group to show a significant difference was
the germ cell tumours, as previously reported (Johnston et
al., 1986). For all groups together a total of 60 case children
had malfonnations, compared with 27 in the control group, a
highly significant difference, P<0.001. The excess of malfor-
mations in all the patients with embryonal tumours grouped
together (Wilms', neuroblastoma, retinoblastoma, hepato-
blastoma and germ cell tumours) was statistically significant
(C18, GP controls 7, P<0.05).
In Table III the nature of the malformations recorded in
the case children is described for each diagnostic group and
in Table IV the malformations recorded in the GP controls
are listed. The anomalies observed were of many types and
affected most organs and systems.
The commoner anomalies are summarised as a case-
control comparison in Table V. A total of eight case children
had chromosomal or genetic conditions of which a number
are already known to pre-dispose to malignancy. Of these,
Down's syndrome was present in three children with leu-
kaemia, and a child with X-linked XY gonadal dysgenesis
had gonadoblastoma (previously reported, Mann et al.,
1983). Also, a boy with skin lesions and IgA deficiency had
adenocarcinoma of the caecum and later died of non-
Hodgkin's lymphoma; his brother, who also had skin lesions,
IgA deficiency and cystic hygroma had glioblastoma multi-
Table I Numbers of relatives with congenital malformations
Case GP control Hospital control
Number of index children with malformationsa 555 555 555
60 (10.8%) 27 (4.9%) -
Number of siblings studied with malformationsa 843 779 814
35 (4.2%) 38 (4.9%) 42 (5.2%)
Number of parents studied with malformationsa 1,086 1,090 1,078
28 (2.7%) 15 (1.4%) 18 (1.7%)
Number of grandparents studied with malformationsb 2,113 2,108 2,149
17 (0.8%) 28 (1.3%) 14 (0.7%)
Number of other relatives studied with malformationsb 7,836 8,199 7,522
205 (2.6%) 175 (2.1%) 205 (2.7%)
aOnly malformations confirmed by inspection of medical records were included. bAll malformations reported at interview
were included.
Table II Number of index children with congenital malformations
No. of case No. of GP control
children with children with
Diagnostic group No. malformations malformations Significance
Acute lymphoblastic leukaemia 148 11 8 NS
Other leukaemias 23 3 0 NS
Hodgkin's disease 32 4 1 NS
Other lymphomas 31 3 4 NS
Central nervous system tumours 78 10 3a NS
Soft tissue sarcoma 43 6 1 NS
Bone tumours 30 3 2 NS
Wilms' tumour 32 5 1 NS
Neuroblastoma 35 4 4 NS
Retinoblastoma 6 0 1 NS
Hepatoblastoma 6 2 0 NS
Germ cell tumours 41 7 1 P <0.05
Epithelial tumours 22 1 0 NS
Other neoplasms 28 1 1 NS
Total 555 60 27 P <0.001
NS = P >0.05 - not significant. aFour were reported in the paper by Birch et al. (1990) but one was a
hairy mole/naevus and therefore was excluded from this paper.CONGENITAL ABNORMALITIES IN CHILDREN WITH CANCER 359
Table III Congenital malformations in case children
Diagnosis
Acute lymphoblastic leukaemia
Other leukaemias
Hodgkin's disease
Other lymphomas
Central nervous system
Soft tissue sarcoma
Bone tumours
Wilms' tumour
Neuroblastoma
Hepatoblastoma
Germ cell tumours
Epithelial tumours (carcinoma of
caecum and later
non-Hodgkin's lymphoma)
Multiple large plexiform
neurofibromas
Description of malformation
Down's syndrome (Trisomy 21)
Down's syndrome mosaic (80% of karyotype 47XY)
Goldenhar's syndrome
Coarctation of aorta and bilateral valgus deformity of feet
Undescended testes
Glandular hypospadiasa
Encysted hydrocoele of spermatic cord
Hip deformity
Large skulla
Ptosis left eyelid
Bowed legs - internal tibial torsion, inguinal herniaa
Down's syndrome
Spina bifida and hydrocephalus
Varus deformity of foot
Ventricular septal defect
Pyloric stenosis
Talipes and malformed toe
Supernumerary thumb
Hypertrophy and port wine stain of arm, and. naevi of trunk
Undescended testis
Polycystic kidneys
Bilateral undescended testes
Undescended testis
Unstable hips
Dislocated hip
Talipes equino varus
Bilateral metatarsus varus
Scoliosis, squint,a pigeon chest
Epicanthic foldsa
Sternomastoid tumoura
Left auricular sinus
Tongue tie
Deep sacral dimple and raised AFP in pregnancy
Hypospadias and club foot
Undescended testis
Absent phalanx left 5th finger and bilateral clinodactyly
Over-riding 2nd and 3rd toes left foot and right 4th toe sticks forwarda
Meningomyelocoele
Absent left kidney and uretera
Low set ears, 'clicking' hips, haemangioma of left leg, genitals and buttocks
Plagiocephaly
Dislocated hip
Bilateral talipes equino varus, low set ears, short palpebral fissuresa
Kyphoscoliosis, short neck, multiple spinal anomalies, absent ribs, large tongue, small fontanelle, spina bifida occulta, accessory nipple and hirsutism
Sinus and spina bifida at Sl
Cleft palate
Patent ductus arteriosus
Tuft of hair over lumbar spine
Sacral dimplea
Ventricular septal defect
Small penis and red pigmentation of arm
Heart murmur? VSD
Cervical meningocoele
Bilateral undescended testes
X-linked XY gonadal dysgenesis
Duplex kidney with reflux and pyelonephritisa
Right metatarsus varusa
Bilateral bat earsa
Skin lesions, IgA deficiency, (brother with skin lesions, IgA deficiency, cystic hygroma, glioma and carcinoma of rectum)
Von Recklinghausen's neurofibromatosis
aCondition which was noted from inspection of medical records, not reported at interview.
forme and carcinoma of the rectum. These boys have been
reported elsewhere (Al Sheyyab et al., 1993). A child with
von Recklinghausen's neurofibromatosis had multiple large
plexiform neurofibromas, a child with polycystic kidneys had
a lymphoma and a child with Goldenhar's syndrome had
leukaemia. In contrast, only one child in the GP control
group had a chromosomal/genetic disorder, which was a ring chromosome 16/17 associated with low set ears and talipes. The case/control excess for chromosomal/genetic disorders
was 8 to 1. For neural tube defects (including spina bifida
occulta) the excess was 5 to 0; this difference is not stati-
stically significant (P>0.05). The neural tube defects were360 J.R. MANN et al.
Table IV Congenital malformations in GP control children
Description of malformations
Pigeon chesta
Hypospadias
Peno-scrotal webbinga
Umbilical hernia and pylorospasm
Metatarsus varus (± other abnormalities of legs/feet)
Metatarsus varus and bilateral ptosis
Valgus deformity of feet (and knees in 1)
Talipes
Dislocated hip(s) (and umbilical hernia in 1)
Sternomastoid tumour
Undescended testis (testes)a
Poorly developed skull bones, occipital narrowing, haemangioma buttock
Bilateral trigger thumba
Bilateral genu valgus
Webbing 1st and 2nd toes both feet
Tongue tiea
Ring chromosome 16/17, low set ears, talipes
Sacral dimple
Bilateral pre-auricular sinuses
aCondition which was noted from inspection of medical records, not reported at interview
Table V Case-control comparison of malformations in index children
Type of malformation No. of cases affected No. of GP controls affected
Chromosomal anomalies 3 1
Single-gene disorders 5 0
Neural tube defects (including 5 0
spina bifida occulta)
Sacral dimple/hair 3 1
Congenital heart disease/murmur 5 0
Hypospadias 2 1
Undescended testicle(s) 6 2
Positional hip, leg and foot deformities 15 13
present in cases with leukaemia (1), Ewing's tumour (1),
Wilms' tumour (2) and germ cell tumour (1). In one of these
the spina bifida occulta was part of a syndrome of multiple
abnormalities (Wilms' tumour - see Table III). When
chromosomal/genetic disorders were excluded there remained
a statistically significant case/control excess of abnormalities
(52 in cases and 26 in controls, <0.01). Congenital heart
disease/murmur was present in five cases but no controls;
undescended testicle was commoner (though not significantly)
in cases than controls. No significant case/control difference
was present for positional hip, leg and foot deformities.
Siblings andparents
There were no differences between case and control groups in
the proportions of siblings with malformations either for the
groups as a whole or for the diagnostic sub-groups.
Chromosomal/genetic anomalies were present in two case
siblings (Down's syndrome, Prader-Willi syndrome), two HC
siblings (both Down's syndrome) and three GPC siblings
(two Turner's syndrome, one Down's syndrome). Neural
tube defects were present in three case, three GPC and eight
HC siblings. In two case families more than one sibling had
congenital anomalies compared with 0 GPC and two HC
families.
There was a significant difference for the numbers of
mothers with anomalies in the case group as a whole when
compared with the GPC group (22/555 vs 8/555, P<0.05).
However, the difference between case and HC mothers (22/
555 vs 14/555) did not reach statistical significance. Seven
case fathers, seven GPC fathers and four HC fathers were
affected. The numbers of neural tube defects found in case
and control parents were similar (two case, three GPC, one
HC). A father of a child with a germ cell tumour had
bilateral cystic kidneys and hypergammaglobulinaemia
(Figure 1) and the mother of a case child with neurofibro-
matosis had a hare lip, numerous birthmarks and naevi and
an epithelial polyp; one
matosis.
HC parent also had neurofibro-
Grandparents and other relatives
There were no significant differences between cases and con-
trols in the total numbers of malformations reported at
interview in these relatives. However, there appears to have
been some under-reporting of malformations in grand-
parents, as the proportions with reported malformations
among these relatives were substantially lower than among
the other groups.
Among the other relatives group (uncles, aunts, cousins,
half-aunts and uncles) there were similar percentages of indi-
viduals with malformations in the case and control groups
overall. However, a statistically significant excess of con-
genital anomalies was found in case compared with GPC
relatives in the acute lymphoblastic leukaemia diagnostic sub-
group (49/1943 vs 33/2413, P<0.01) and specifically an
excess of neural tube defects was reported in the case
relatives (cases 8/1943, GP controls 1/2413, P<0.05). The
soft tissue sarcoma group showed an excess of anomalies
between case and GP control relatives (24/256 vs 10/585,
P<0.01) as did the neuroblastoma group (18/416 vs 13/648,
P<0.05). Significantly more anomalies in case than HC
relatives were found in the Wilms' tumour group (16/449 vs
4/618, P<0.01), and in the bone tumour group (15/565 vs
4/492, P<0.05), but significant excesses were also found in
HC vs case relatives in the Hodgkin's disease group (18/356
vs 10/617, P<0.05) and in GPC vs case relatives in the
central nervous system tumours group (46/959 vs 30/1104,
P<0.05). These results are difficult to interpret because of
the large number of statistical tests that have been carried
out. We report these findings for the sake of completeness,
but would not attach any weight to them unless similar
findings are reported from independent studies. In analysing
these rates we have used chi-square tests ignoring both the
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Figure I Pedigree of a boy with a teratoma.
matching of cases and controls and the possible correlations
between relatives. This is a further reason for treating these
results with some caution.
Familypedigrees
Few pedigrees showed familial patterns of malformation and
cancer. Those which were of interest included X-linked XY
gonadal dysgenesis (Mann et al., 1983) and brothers with
colorectal carcinoma and also, respectively, non-Hodgkin's
lymphoma and glioma (Al Sheyyab et al., 1993). Also, there
were several individuals with neural tube defects in the family
of a boy who had Goldenhar's syndrome and acute lym-
phoblastic leukaemia (Figure 2) and polycystic kidneys,
neurofibromatosis, cerebellar tumour, diabetes and fronto-
nasal dysplasia in the relatives of a boy with teratoma
(Figure 1).
Discussion
There have been a number of reports that children with
cancer have a higher incidence of malformations than do
healthy children and many specific malformation/cancer syn-
dromes and conditions predisposing to malignancy have been
described (Schimpke, 1978; Knudson, 1986; Dodet & Lenoir,
1990). The genetic basis for many of these is now understood
(Yunis, 1983; Green, 1988).
Miller et al. (1964) described congenital malformations in
66 (15%) of 440 cases of Wilms' tumour, including aniridia,
microcephaly, mental retardation, hemihypertrophy, naevi,
urinary-tract anomalies, gonadal anomalies and miscel-
laneous other defects. Thirteen per cent of 369 children with
germ cell tumours reported by Fraumeni et al. (1973) had
congenital malformations and Birch et al. (1982) drew parti-
cular attention to an excess of neural tube defects in children
with germ cell tumours and their siblings. Among 115 child-
ren who died of rhabdomyosarcoma 37 (32%) were found at
autopsy to have malformations of the central nervous,
genitourinary, gastrointestinal and cardiovascular systems
(Ruymann et al., 1988); among them were single cases of
Rubinstein-Taybi syndrome, neurofibromatosis, horseshoe
kidney, hemihypertrophy and Arnold-Chiari malformation.
Also of 42 children with liver tumours nine (21%) had
congenital defects or other possibly related features, includ-
ing hemi-hypertrophy, Beckwith-Wiedemann syndrome, renal
dysplasia, undescended testis, tyrosinosis, neonatal hepatitis,
bifid ureters and a family history of polyposis coli (Mann et
al., 1990).
Most such reports of an excess of malformations among
children with cancer have used figures from normal popula-
tions for comparison. However, there are many difficulties
inherent in using population figures as was described by Leck
(1983). For example improved neonatal care may lead to an
increase in the prevalence of malformations because more
malformed infants may survive, while the overall incidence
would be unaffected. Incomplete ascertainment is a problem,
particularly for minor malformations and for stillbirths and
neonatal deaths. Diagnoses may be inaccurate or malforma-
tions diagnosed may not be notified. Active programmes for
ante-natal diagnosis and abortion of malformed foetuses can
reduce the incidence ofcertain malformations, notably neural
tube defects and Down's syndrome. Malformation rates are
affected by social and other factors such as race, maternal
age and parity, socio-economic status and parental consan-
guinity. The proportion of British children born with 'lethal
and handicapping' malformations was about 2.5% using data
based on work in Birmingham in the 1950's (Leck et al.,
1968) and other British sources (Leck, 1983), but less serious
malfomations were not included in this figure. Data from the
National Children's Bureau 1958 Cohort Study and other
sources suggested that in the 1960's between 3 and 4% oflive
and stillborn infants had serious defects (Wells, 1978).
It is thus clear than an assessment of the relevance of any
apparent excess number of malformations in children with
cancer and their relatives is best made by a case-control
study with contemporary well-matched controls. Therefore,
for our study we used two types of control for each case: a
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child registered with the same general practice as the case
(GP control) and a child admitted to hospital for an acute
medical or surgical condition other than cancer (hospital
control), both controls matched for age and sex with the
case. As we specifically excluded as hospital controls children
with conditions known to be associated with malignancy and
certain other major malformations and diseases, the case-
control comparisons for the index children could be made
only between the cases and the GP control children. How-
ever, we did not consider it necessary to exclude the relatives
of hospital controls from the case-control analyses for
relatives.
The proportions ofchildren with malformations among the
GP controls (4.9%) and the siblings of the cases (4.2%), GP
controls (4.9%) and hospital controls (5.2%) were similar.
The malformations included the 'lethal and handicapping'
conditions which affected 2.5% of the populations reviewed
by Leck (1983) and also many less serious conditions as listed
in Chapter XIV of ICD9 (WHO, 1977). Medical records were
examined specifically for malformations and only those
recorded in them were included in the analyses. Therefore the
excess of malformations in the case children appears to be a
genuine finding, particularly in view of the considerable
excess ofchromosomal/genetic anomalies, neural tube defects
and other serious conditions. If the 'natural' incidence of
malformations in the childhood population in the three
regions was about 5%, then the excess malformations which
can be presumed to be associated with the malignancies was
just over 5% i.e. about one in twenty children with cancer
may have a cancer/malformation syndrome, the cancer and
the malformation perhaps sharing the same aetiology at
molecular genetic level. This has already been shown to be
the case for certain cancer/malformation syndromes, for
example Wilms' tumour/aniridia (Riccardi et al., 1978).
Study of the family pedigrees of our cases showed that very
few of the children with cancer and malformations had
similarly affected relatives. Thus in the majority the event
leading to both the cancer and the malformation can be
presumed to have occurred in the ovum or sperm or after
fertilisation. Ante-natal irradiation did not appear to be re-
sponsible, and all the mothers' pelvic X-rays were performed
late in pregnancy.
The excess of malformations in the case children was not
confined to certain diagnostic sub-groups but was evident in
nearly all of them, although did not reach statistical
significance except in the germ cell tumours sub-group.
The case-control comparisons for the numbers of malfor-
mations in parents, grandparents and other relatives showed
no striking differences, with the possible exception that
significantly more mothers of cases had malformations than
did mothers of GP controls; this result may have occurred by
chance since the differences between mothers of cases and
Hospital Controls and the comparisons for diagnostic sub-
groups were not significant. Also the numbers of affected
individuals were small. It is interesting but perhaps not sur-
prising that the percentages of parents, grandparents and
other relatives with malformations were substantially lower
than the figures for the index children and their siblings. Two
explanations could account for this. Firstly, individuals with
'lethal and severely handicapping' malformations would have
been unlikely to have achieved parenthood, grandparenthood
etc. Leck et al. (1983) reported that such malformations
affected 2.5% of persons in British populations. This figure
added to the 34/2176 = 1.6% of control (HP + GPC) parents
with malformations gives 4.1%, quite similar to the rates
among GP control index children and siblings of cases and
controls. Likewise, in the 'other relatives' group, the figure of
2.5% added to the 380/15721 = 2.4% of control (HC + GPC)
'other relatives' gives 4.9%. Secondly, the mothers of the
index children, from whom the data were obtained at inter-
view, were likely to have been less well informed about
malformations (especially minor ones) in their more distant
relatives than in their children, i.e. there was probably an
element of under-reporting, mainly for grandparents.
Neural tube defects had occurred in paternal and maternal
relatives of the child with Goldenhar's syndrome (oculo-
auriculo-vertebral dysplasia, coloboma of the eyelid, dermoid
of conjunctiva, accessory auricular appendages, hypoplastic
zygomatic arches) and acute lymphoblastic leukaemia (Figure
2). The relationship between these conditions is unclear and
so is that between the various conditions in the pedigree of a
child with a teratoma (Figure 1).
Our study suggests that the excess of malformations found
in children with cancer, compared with controls, without a
similar excess of malformations in their close relatives may
indicate that in some cases, perhaps about one in twenty,
antenatal events may lead both to the malformation and the
malignancy.
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